GEROPHARM, Group of Companies entered the Top-10 largestcompanies according to the national rating of Russian high-tech fast developing companies TechUspekh-2013. This year, the results of the rating confirmed the correctness of the last year assessment
The Forum was organised by the Industrial Politics and Innovations Committee of Saint Petersburg and the Non-Commercial Partnership Medical and Pharmaceutical Projects. XXI century. The event is supported by the Ministry of Economic Development, the Ministry of Industry and Trade, the Ministry of Health of the Russian Federation and the Government of Saint Petersburg. It is the third time for the last three years when GEROPHARM becomes a partner of such industry-important event.
A unique feature of the Life Sciences Invest Forum is its format, as it includes round-tables, practical master-classes and partnering which allows it becoming a platform for live business communications between the main market participants every year. This year, the representatives of GEROPHARM took part in several sections of the business and training program.
The General Director of GEROPHARM reported during the round-table discussion Innovative Infrastructure Development for High Tech Industries.
The event was attended by Vice-President of the Saint Petersburg Industrial Policy and Innovations Committee Inna Shalyto; General Director of the Russian Union of Industrialists and Entrepreneurs Aleksandr Gabitov; General Director of Business Incubator Ingria Igor Rozhdestvenskiy; Chief Executive Officer of FinnMedi Matti Eskola; General Director of Non-Commercial Partnership Medical and Pharmaceutical Projects. XXI century Dmitriy Chagin; Chairman of Management Board of Medical and Pharmaceutical Projects. XXI century Zakhar Golant and others.
During the discussion the round-table participants spoke about the problems and perspectives of development of urban innovation infrastructure, the idea of creation of an integrated cluster for Saint Petersburg and the Leningrad Region, the lack of the personnel having competence in priority industries and its training.
“The country faced an economic crisis in 2008, and it turned out that the pharmacological industry became important. The creation of pharmacological cluster in Saint Petersburg was started in 2009,” says General Director of GEROPHARM, Group of Companies Pyotr Rodionov. “Here in Petersburg, we have managed to get highly skilled specialists involved who earlier leaved the country to work abroad. Petersburg is a preferable place for those companies that start from the very beginning, because here you can find a fundamental historical scientific base. In spite of a number of difficulties related to the preferences we have that, as we hope, are the temporary ones, we continue to work and are sure that we will manage to monetize these preferences in the future. This also concerns the preferences for the Russian manufacturers in public procurement, as we often have to fight even for our internal market although we are ready to enter the external one. There is no doubt that the product manufacturers are growing, but we could make it faster”.
Summing up the round-table discussions, the speakers agreed that Petersburg needs synergy of science, cumulative experience, infrastructure and innovative ideas for further development and moving to the next level.
HR-Director Natalia Skakunova took part in the round-table discussion Practical Approaches to Search and Training of Personnel for the Pharmaceutical and Biotechnological Industries. Natalia shared with other participants GEROPHARM’s experience in the development and implementation of student and graduate programs. GEROPHARM understands that the future of the Russian pharmaceutics depends a lot on the talented and initiative youth. That is why GEROPHARM supports joint projects with leading specialized high educational institutions including those initiated by the Saint Petersburg Chemical-Pharmaceutical Academy (SPCPA).
Quality Director of GEROPHARM, group of companies Natalia Novichkova was a speaker of the section Integration of the Production Quality Control System as Part of Transfer to GMP Standards. Using the opening of the GEROPHARM-Bio plant (the beginning of the October this year) as an example, she presented to the audience, including the SPCPA students, the case with the information about the steps to be followed by a company and the rules to be used to integrate the modern good manufacturing standards at an enterprise.